OCUL PEER ANALYSIS

Ocular Therapeutix Inc — metric-by-metric comparison with peers and the industry median

OCULOcular Therapeutix Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

OCULIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	OCUL	TLX	MSB	CSL	Ind. Median
P/E	—	—	—	29.44	17.91
P/B	3.71	6.37	—	2.20●	3.51
EV/EBITDA	—	120.14	—	10.21●	14.82
P/S	41.51	3.24	31.61	2.62●	10.89

Financial Health
Metric	OCUL	TLX	MSB	CSL	Ind. Median
Current Ratio	14.81●	1.43	—	2.57	5.90
Debt/Equity	13.7%●	112.3%	—	67.4%	10.9%
NetDebt/EBITDA	2.14●	13.13	—	2.22	1.15

Profitability
Metric	OCUL	TLX	MSB	CSL	Ind. Median
Net Margin	-558.2%	-0.9%	-115.3%	9.2%●	-125.7%
ROE	-68.6%	-1.8%	-11.3%	7.7%●	-47.5%
ROA	-51.0%	-0.7%	-8.6%	3.8%●	-35.8%
EBITDA Margin	-527.0%	3.0%	-76.6%	32.8%●	-105.8%

Growth + Dividend
Metric	OCUL	TLX	MSB	CSL	Ind. Median
Rev. Growth	-12.8%	56.3%	410.4%●	4.8%	5.1%
NI Growth	—	—	—	-39.4%	12.1%
Div. Yield	—	—	0.0%	2.5%●	0.2%
Payout	—	—	0.0%	103.1%	0.0%

Valuation
Metric	OCUL	NUVB	AUPH	ADMA	HRMY	AGIO	Ind. Median
P/E	—	—	7.20●	12.99	15.04	—	17.91
P/B	3.71	6.73	3.79	5.50	2.41	1.99●	3.51
EV/EBITDA	—	—	11.36	9.99	7.52●	—	14.82
P/S	41.51	15.04	7.20	4.21	2.44●	33.45	10.89

Financial Health
Metric	OCUL	NUVB	AUPH	ADMA	HRMY	AGIO	Ind. Median
Current Ratio	14.81●	7.44	5.55	6.95	3.58	14.19	5.90
Debt/Equity	13.7%	3.1%●	12.1%	52.4%	22.7%	3.2%	10.9%
NetDebt/EBITDA	2.14	4.04	-1.92●	0.30	-1.86	1.68	1.15

Profitability
Metric	OCUL	NUVB	AUPH	ADMA	HRMY	AGIO	Ind. Median
Net Margin	-558.2%	-102.1%	100.0%●	32.4%	16.2%	-639.8%	-125.7%
ROE	-68.6%	-39.5%	65.0%●	43.3%	17.9%	-32.8%	-47.5%
ROA	-51.0%	-26.5%	48.5%●	28.1%	12.5%	-30.8%	-35.8%
EBITDA Margin	-527.0%	-90.7%	54.2%●	43.4%	26.0%	-633.4%	-105.8%

Growth + Dividend
Metric	OCUL	NUVB	AUPH	ADMA	HRMY	AGIO	Ind. Median
Rev. Growth	-12.8%	1,205.5%●	20.6%	11.0%	20.7%	78.3%	5.1%
NI Growth	—	—	648.4%●	-20.0%	-4.7%	—	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on OCUL

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.